{"brief_title": "Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function", "brief_summary": "The purpose of this study is to evaluate the safety of injections of botulinum toxin Type A in patients with reduced lung function and focal upper limb poststroke spasticity", "condition": ["Stroke", "Muscle Spasticity", "Motor Neuron Disease"], "intervention_type": ["Biological", "Biological", "Drug"], "intervention_name": ["botulinum toxin Type A", "botulinum toxin Type A", "saline"], "description": ["botulinum toxin Type A 240 U injection on Day 1, Week 12, Week 18", "botulinum toxin Type A 360 U injection at Day 1, Week 12, Week 18", "Saline injection at Day 1, Week 12, Week 18"], "arm_group_label": ["1", "2", "3"], "other_name": ["BOTOX\u00ae", "BOTOX\u00ae"], "criteria": "Inclusion Criteria: - Abnormal pulmonary function test results; - focal, upper limb spasticity, upper motor neuron syndrome Exclusion Criteria: - Previous exposure to botulinum toxin of any serotype", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Stroke", "Motor Neuron Disease", "Muscle Spasticity", "Botulinum Toxins, Type A", "incobotulinumtoxinA", "abobotulinumtoxinA", "onabotulinumtoxinA", "Botulinum Toxins"], "id": "NCT00076687"}